Texas Instruments’ Margin Recovery Meets a 39.4x P/E

The recovery accelerated. Texas Instruments reported Q2 FY2026 revenue of $5.46 billion, up 13% sequentially and 23% from Q2 FY2025. Management described the growth as broad, led by industrial, data center and automotive demand. Analog revenue increased 26% year over year to $4.37 billion, while Embedded Processing grew 16% to $788 million. Other revenue declined 2% to $310 million. These results indicate that the improvement was centered in the two operating franchises rather than being produced by a non-core item, according to the Texas Instruments Q2 FY2026 earnings release.

Margins changed even faster than revenue. Gross profit rose to $3.35 billion from $2.58 billion, taking gross margin to 61.4% from 57.9% a year earlier and 58.0% in Q1 FY2026. Operating profit increased 48% year over year to $2.31 billion, and operating margin reached 42.3%, compared with 35.1% a year earlier and 37.5% in the preceding quarter. Analog operating profit grew 50% to $1.99 billion; Embedded Processing operating profit nearly doubled to $168 million. The quarter therefore provided direct evidence that stronger volume and manufacturing utilization are restoring operating leverage.

EPS increased 52% to $2.14 from $1.41. That included a $0.05 benefit not contemplated in the company’s original guidance, so not all of the upside should be treated as recurring. Even excluding that benefit, the direction was clear: operating profit growth substantially exceeded revenue growth. The company guided Q3 FY2026 revenue to $5.65 billion-$6.15 billion and EPS to $2.23-$2.57, giving midpoints of $5.90 billion and $2.40, respectively.

Cash flow also improved, although definitions matter. On the standard operating-cash-flow-less-capital-expenditures definition used in the supplied quarterly table, Q2 free cash flow was $2.19 billion: $2.70 billion of operating cash flow less $514 million of capital expenditures. Texas Instruments reported non-GAAP free cash flow of $2.74 billion because its definition also adds $549 million of CHIPS Act incentive proceeds. The Texas Instruments Form 10-Q for the quarter ended June 30, 2026 provides the underlying cash-flow and balance-sheet figures.

The quarter strengthens the operating case. Texas Instruments’ annual operating margin fell from 50.6% in FY2022 to 34.1% in FY2025 as the semiconductor cycle weakened and the company continued investing in manufacturing capacity. Q2’s 42.3% margin does not fully restore the prior peak, but it shows that the earnings architecture remains highly responsive when revenue recovers. A 23% revenue increase produced a 48% increase in operating profit and a 52% increase in EPS.

The cash-flow inflection is also important. Capital expenditures were $514 million in Q2 FY2026, down from $1.31 billion in Q2 FY2025, while operating cash flow increased to $2.70 billion from $1.86 billion. That combination drove the standard quarterly free-cash-flow improvement to $2.19 billion from approximately $0.56 billion. On the company’s incentive-inclusive definition, trailing-12-month free cash flow reached $6.53 billion, compared with $1.76 billion a year earlier. The supplied valuation snapshot uses the standardized TTM free cash flow of $5.3 billion and a 2.2% yield, rather than adding incentive proceeds.

The balance-sheet and capital-return picture is less changed. Cash was $3.66 billion and debt was $14.05 billion at quarter-end, producing approximately $10.39 billion of net debt before considering short-term investments. Texas Instruments paid $1.30 billion of dividends during the quarter but repurchased only $27 million of stock. Over the trailing 12 months, dividends increased 4% to $5.11 billion while repurchases declined 61% to $707 million, according to the Texas Instruments Q2 FY2026 earnings release. At the current valuation, restraint on repurchases is economically sensible.

The tension is valuation. At $258.82, Texas Instruments trades at 39.4 times TTM EPS of $6.57 and offers a 2.2% standardized TTM free-cash-flow yield. Q2 made a stronger normalized-earnings outcome more plausible, but the share price already assumes that current momentum persists and that manufacturing investment earns attractive returns. FY2025 ROIC was 15.7%, an improvement from 14.2% in FY2024 but still far below the 34.4% recorded in FY2022.

There was no prior SageNoodle valuation to update, so this report establishes rather than moves fair value. We use normalized EPS scenarios because current trailing earnings remain depressed relative to the margin recovery visible in Q2. These are explicit valuation assumptions, not company guidance: the company provided only Q3 revenue and EPS ranges, not multi-year forecasts.

The bear case assigns $150 per share, based on assumed normalized EPS of $6.00 and a 25.0x multiple. It captures a recovery that stalls as industrial or automotive customers resume inventory corrections, leaving manufacturing utilization below the level needed to sustain Q2 margins. The base case assigns $215, based on assumed normalized EPS of $8.00 and a 26.9x multiple. That assumes the recovery continues but that margins settle below the FY2021-FY2022 peak range. The bull case assigns $300, based on assumed normalized EPS of $10.00 and a 30.0x multiple, requiring durable demand, high utilization and strong returns from new capacity.

The $215 base-case fair value is 16.9% below the $258.82 market price, meeting the stated rule for an Overvalued verdict. The scenarios do not deny the quality of the franchise or the strength of Q2. They distinguish a better business result from an attractive entry valuation. EV/EBITDA was not disclosed or derivable from the supplied standardized metrics; the snapshot records zero solely as an unavailable-data sentinel, not as a valuation multiple.

The bearish valuation conclusion would be wrong if Q2 marks the beginning of a longer and more profitable expansion than the base case assumes. Q3 guidance implies sequential growth at its midpoint: $5.90 billion of revenue and $2.40 of EPS. If revenue approaches the top of that range while gross and operating margins continue expanding, normalized EPS could move toward the bull-case assumption faster than expected.

The operating thesis would be wrong in the opposite direction if recent growth reflects temporary inventory replenishment rather than sustained end demand. The company specifically identifies semiconductor demand, customer forecasts and the timing of inventory adjustments as risks. Industrial and automotive were among the leading growth markets in Q2, making their durability particularly important. A renewed correction would pressure revenue and reduce factory utilization, reversing part of the margin recovery.

Manufacturing execution is the other central test. Internal production can create a cost advantage when utilization is high, but fixed costs become a burden when volumes weaken. The company’s filing highlights timely installation of manufacturing equipment, implementation of new technologies and realization of expected returns on capacity investment as material risks. Failure here would keep ROIC below historical levels even if revenue grows.

Finally, reported cash conversion requires careful interpretation. Q2 benefited from $549 million of CHIPS Act cash incentives and a lower quarterly capital-expenditure run rate. Those are real cash benefits, but incentive proceeds are not recurring operating profit. The thesis would weaken if standardized free cash flow failed to keep improving once incentives normalize or if capital spending rises again without a corresponding increase in earnings.